Form 8-K - Current report:
SEC Accession No. 0001564590-21-055442
Filing Date
2021-11-09
Accepted
2021-11-09 07:13:14
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imra-8k_20211109.htm   iXBRL 8-K 40492
2 EX-99.1 imra-ex991_6.htm EX-99.1 202616
3 GRAPHIC gwgxqzzbztnk000001.jpg GRAPHIC 157340
  Complete submission text file 0001564590-21-055442.txt   593529

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imra-20211109.xsd EX-101.SCH 5665
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20211109_lab.xml EX-101.LAB 20078
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20211109_pre.xml EX-101.PRE 11919
7 EXTRACTED XBRL INSTANCE DOCUMENT imra-8k_20211109_htm.xml XML 3665
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 211389848
SIC: 2834 Pharmaceutical Preparations